Description
Lorlatinib (PF-6463922) is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.
Molecular Formula
C21H19FN6O2
Smiles
C[C@H]1OC2CC(CNC2N)-C2C(CN(C)C(=O)C3CCC(F)CC13)NN(C)C2C#N
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
Ethanol: 40.6 mg/mL (100 mM)DMSO: 15 mg/mL (36.91 mM), Sonication is recommended.
Relative Density
1.42 (Predicted)